IDH1 and kidney neoplasm: The L-2HG enantiomer also presents oncometabolic DNA demethylation inhibitory effects in kidney tumors, however this is due to changes in L-2HG dehydrogenase rather than IDH1/IDH2 (Shim et al., 2014).